FDA authorizes Pfizer COVID vaccine booster for children 5 to 11
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.
FDA authorized the Pfizer-BioNTech COVID booster for children aged 5 to 11 five months after they have finished the first two-shot vaccination series.